Spanish scientist’s pancreatic cancer breakthrough turns to crowdfunding as it faces funding shortage for human trials
A promising pancreatic cancer therapy developed by Mariano Barbacid has shown striking results in mice, eradicating tumors without resistance. However, the project faces a significant funding gap for human trials, prompting an unusual crowdfunding campaign. This situation highlights the "valley of death" in biomedical research, where promising discoveries struggle to secure funding for clinical development.
A promising pancreatic cancer therapy developed by Mariano Barbacid has shown striking results in mice, eradicating tumors without resistance. However, the project faces a significant funding gap for human trials, prompting an unusual crowdfunding campaign. This situation highlights the "valley of death" in biomedical research, where promising discoveries struggle to secure funding for clinical development.
